Related Experiment Video
Updated: Mar 17, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Lack of SIRPα phosphorylation and concomitantly reduced SHP-2-PI3K-Akt2 signaling decrease osteoblast differentiation
Cecilia Koskinen Holm1, Sara Engman1, Rima Sulniute1
1Odontology, Section for Molecular Periodontology, Umeå University, 90187, Sweden.
Abstract:
Normal differentiation of bone forming osteoblasts is a prerequisite for maintenance of skeletal health and is dependent on intricate cellular signaling pathways, including the essential transcription factor Runx2. The cell surface glycoprotein CD47 and its receptor signal regulatory protein alpha (SIRPα) have both been suggested to regulate bone cell differentiation. Here we investigated osteoblastic differentiation of bone marrow stromal cells from SIRPα mutant mice lacking the cytoplasmic signaling domain of SIRPα. An impaired osteoblastogenesis in SIRPα-mutant cell cultures was demonstrated by lower alkaline phosphatase activity and less mineral formation compared to wild-type cultures. This reduced osteoblastic differentiation potential in SIRPα-mutant stromal cells was associated with a significantly reduced expression of Runx2, osterix, osteocalcin, and alkaline phosphatase mRNA, as well as a reduced phosphorylation of SHP-2 and Akt2, as compared with that in wild-type stromal cells. Addition of a PI3K-inhibitor to wild-type stromal cells could mimic the impaired osteoblastogenesis seen in SIRPα-mutant cells. In conclusion, our data suggest that SIRPα signaling through SHP-2-PI3K-Akt2 strongly influences osteoblast differentiation from bone marrow stromal cells.
Insights
Signal regulatory protein alpha (SIRPα) is crucial for bone health. Impaired SIRPα signaling disrupts osteoblast differentiation by affecting key gene expression and cellular pathways, impacting skeletal maintenance.
Area of Science:
- Bone Biology
- Cell Signaling
- Osteoblast Differentiation
Background:
- Normal osteoblast differentiation is vital for skeletal health.
- The SIRPα receptor and its role in bone cell regulation are under investigation.
- Runx2 is an essential transcription factor for osteoblastogenesis.
Purpose of the Study:
- To investigate the role of SIRPα signaling in osteoblastic differentiation.
- To analyze osteoblast differentiation in SIRPα mutant mice lacking the cytoplasmic signaling domain.
- To elucidate the molecular mechanisms by which SIRPα influences osteoblastogenesis.
Main Methods:
- Culturing bone marrow stromal cells from SIRPα mutant and wild-type mice.
- Assessing alkaline phosphatase activity and mineral formation.
- Quantifying mRNA expression of key osteogenic markers (Runx2, osterix, osteocalcin, alkaline phosphatase).
- Analyzing protein phosphorylation of SHP-2 and Akt2.
- Utilizing a PI3K inhibitor to mimic impaired osteoblastogenesis.
Main Results:
- SIRPα-mutant cell cultures exhibited impaired osteoblastogenesis.
- Reduced alkaline phosphatase activity and mineral formation were observed in mutant cultures.
- SIRPα deficiency led to decreased expression of Runx2, osterix, osteocalcin, and alkaline phosphatase mRNA.
- Phosphorylation of SHP-2 and Akt2 was significantly reduced in SIRPα-mutant cells.
- PI3K inhibition mimicked the impaired osteoblastogenesis in wild-type cells.
Conclusions:
- SIRPα signaling is essential for normal osteoblast differentiation from bone marrow stromal cells.
- The SIRPα-SHP-2-PI3K-Akt2 pathway plays a critical role in regulating osteogenesis.
- Understanding this pathway offers potential targets for skeletal health interventions.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
Bone Remodeling

